Our findings on the positive association between copeptin and incident prediabetes/T2D among normoglycaemic participants at baseline are in accordance with findings from the DESIR study [15] showing a positive association between copeptin and incident IFG/T2D among participants with normal fasting glucose at baseline. Here, AVP is linked to prediabetes syndrome.